Regulated Hyaluronan Synthesis by Vascular Cells

International Journal of Cell Biology

Volumn 2015, Issue , 2015, Pages

  Viola, Manuela ^a   Karousou, Evgenia ^a   D'Angelo, Maria Luisa ^a   Caon, Ilaria ^a   De Luca, Giancarlo ^a   Passi, Alberto ^a   Vigetti, Davide ^a  

^a UNIVERSITY OF INSUBRIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HYALURONIC ACID; LOW DENSITY LIPOPROTEIN;

ATHEROSCLEROSIS; CELLS BY BODY ANATOMY; ENDOTHELIUM CELL; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; SYNTHESIS; VASCULAR CELL; VASCULAR DISEASE; VASCULAR SMOOTH MUSCLE CELL;

EID: 84942257288     PISSN: 16878876     EISSN: 16878884     Source Type: Journal    
DOI: 10.1155/2015/208303     Document Type: Review

References (74)

1. V. L. Roger, A. S. Go, D. M. Lloyd-Jones et al., Heart disease and stroke statistics2012 update: a report from the American HeartAssociation, Circulation, vol. 125, no. 1, pp. e2e220, 2012.
2. P. M. Vanhoutte, "Endothelial dysfunction-the first step toward coronary arteriosclerosis," Circulation Journal, vol. 73, no. 4, pp. 595-601, 2009.
3. M. J. Merrilees, B. W. Beaumont, K. R. Braun et al., "Neointima formed by arterial smooth muscle cells expressing versican variant V3 is resistant to lipid and macrophage accumulation," Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 31, no. 6, pp. 1309-1316, 2011.
4. B. Messner and D. Bernhard, "Smoking and cardiovascular disease: mechanisms of endothelial dysfunction and early atherogenesis," Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 34, no. 3, pp. 509-515, 2014.
5. L. Badimon and G. Vilahur, "LDL-cholesterol versus HDLcholesterol in the atherosclerotic plaque: inflammatory resolution versus thrombotic chaos," Annals of the New York Academy of Sciences, vol. 1254, no. 1, pp. 18-32, 2012.
6. J. X. Rong, M. Shapiro, E. Trogan, and E. A. Fisher, "Transdifferentiation ofmouse aortic smoothmuscle cells to a macrophagelike state after cholesterol loading," Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 23, pp. 13531-13536, 2003.
7. J. G. Dickhout, Š. Lhoták, B. A. Hilditch et al., "Induction of the unfolded protein response after monocyte to macrophage differentiation augments cell survival in early atherosclerotic lesions," The FASEB Journal, vol. 25, no. 2, pp. 576-589, 2011.
8. D. Vigetti, P. Moretto, M. Viola et al., "Matrixmetalloproteinase 2 and tissue inhibitors of metalloproteinases regulate human aortic smooth muscle cell migration during in vitro aging," The FASEB Journal, vol. 20, no. 8, pp. 1118-1130, 2006.
9. R. Ross, "Atherosclerosis-an inflammatory disease," The New England Journal of Medicine, vol. 340, no. 2, pp. 115-126, 1999.
10. D. Jiang, J. Liang, and P. W. Noble, "Hyaluronan in tissue injury and repair," Annual Review of Cell and Developmental Biology, vol. 23, pp. 435-461, 2007.
11. D. Jiang, J. Liang, and P. W. Noble, "Hyaluronan as an immune regulator in human diseases," Physiological Reviews, vol. 91, no. 1, pp. 221-264, 2011.
12. E. G. Karousou, M. Viola, A. Genasetti et al., "Application of polyacrylamide gel electrophoresis of fluorophore-labeled saccharides for analysis of hyaluronan and chondroitin sulfate in human and animal tissues and cell cultures," Biomedical Chromatography, vol. 19, no. 10, pp. 761-765, 2005.
13. R. H. Tammi, A. G. Passi, K. Rilla et al., "Transcriptional and post-translational regulation of hyaluronan synthesis," FEBS Journal, vol. 278, no. 9, pp. 1419-1428, 2011.
14. D. Vigetti, M. Viola, E. Karousou, G. de Luca, and A. Passi, "Metabolic control of hyaluronan synthases," Matrix Biology, vol. 35, pp. 8-13, 2014.
15. S. P. Evanko, J. C. Angello, and T. N. Wight, "Formation of hyaluronan-and versican-rich pericellular matrix is required for proliferation and migration of vascular smooth muscle cells," Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 19, no. 4, pp. 1004-1013, 1999.
16. D. Vigetti, M. Viola, E. Karousou et al., "Hyaluronan-CD44-ERK1/2 regulate human aortic smooth muscle cell motility during aging," The Journal of Biological Chemistry, vol. 283, no. 7, pp. 4448-4458, 2008.
17. D. Kothapalli, L. Zhao, E. A. Hawthorne et al., "Hyaluronan and CD44 antagonize mitogen-dependent cyclin D1 expression in mesenchymal cells," The Journal of Cell Biology, vol. 176, no. 4, pp. 535-544, 2007.
18. J. C. Monboisse, J. B. Oudart, L. Ramont, S. Brassart-Pasco, and F. X. Maquart, "Matrikines from basement membrane collagens: a new anti-cancer strategy," Biochimica et Biophysica Acta, vol. 1840, no. 8, pp. 2589-2598, 2014.
19. D. Vigetti, E. Karousou, M. Viola, S. Deleonibus, G. deLuca, and A. Passi, "Hyaluronan: biosynthesis and signaling," Biochimica et Biophysica Acta (BBA)-General Subjects, vol. 1840, no. 8, pp. 2452-2459, 2014.
20. M. Nardini, M. Ori, D. Vigetti, R. Gornati, I. Nardi, and R. Perris, "Regulated gene expression of hyaluronan synthases during Xenopus laevis development," Gene Expression Patterns, vol. 4, no. 3, pp. 303-308, 2004.
21. P. Estess, A. Nandi, M. Mohamadzadeh, and M. H. Siegelman, "Interleukin 15 induces endothelial hyaluronan expression in vitro and promotes activated T cell extravasation through a CD44-dependent pathway in vivo," The Journal of Experimental Medicine, vol. 190, no. 1, pp. 9-19, 1999.
22. D. Vigetti and A. Passi, "Hyaluronan synthases posttranslational regulation in cancer," in Advances in Cancer Research, vol. 123, pp. 95-119, Elsevier, 2014.
23. M. Afanasyeva, D. Georgakopoulos, D. F. Belardi et al., "Quantitative analysis of myocardial inflammation by flow cytometry in murine autoimmune myocarditis: correlation with cardiac function," The American Journal of Pathology, vol. 164, no. 3, pp. 807-815, 2004.
24. K. L. Brown, A. Maiti, and P. Johnson, "Role of sulfation in CD44-mediated hyaluronan binding induced by inflammatory mediators in human CD14+ peripheral blood monocytes," Journal of Immunology, vol. 167, no. 9, pp. 5367-5374, 2001.
25. S. Shahrara, C. C. Park, V. Temkin, J. W. Jarvis, M. V. Volin, and R. M. Pope, "RANTES modulates TLR4-induced cytokine secretion in human peripheral blood monocytes," Journal of Immunology, vol. 177, no. 8, pp. 5077-5087, 2006.
26. C. Termeer, F. Benedix, J. Sleeman et al., "Oligosaccharides of hyaluronan activate dendritic cells via Toll-like receptor 4," Journal of Experimental Medicine, vol. 195, no. 1, pp. 99-111, 2002.
27. S. Reitsma, D. W. Slaaf, H. Vink, M. A. M. J. van Zandvoort, and M. G. A. Oude Egbrink, "The endothelial glycocalyx: composition, functions, and visualization," Pflugers Archiv European Journal of Physiology, vol. 454, no. 3, pp. 345-359, 2007.
28. B. M. vanden Berg, H. Vink, and J. A. E. Spaan, "The endothelial glycocalyx protects against myocardial edema," Circulation Research, vol. 92, no. 6, pp. 592-594, 2003.
29. A. A. Constantinescu, H. Vink, and J. A. E. Spaan, "Endothelial cell glycocalyx modulates immobilization of leukocytes at the endothelial surface," Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 23, no. 9, pp. 1541-1547, 2003.
30. H. Vink, A. A. Constantinescu, and J. A. E. Spaan, "Oxidized lipoproteins degrade the endothelial surface layer: implications for platelet-endothelial cell adhesion," Circulation, vol. 101, no. 13, pp. 1500-1502, 2000.
31. N. Nagy, T. Freudenberger, A. Melchior-Becker et al., "Inhibition of hyaluronan synthesis acceleratesmurine atherosclerosis: novel insights into the role of hyaluronan synthesis," Circulation, vol. 122, no. 22, pp. 2313-2322, 2010.
32. T. Nakamura, K. Takagaki, S. Shibata, K. Tanaka, T. Higuchi, and M. Endo, "Hyaluronic-acid-deficient extracellular matrix induced by addition of 4-methylumbelliferone to the medium of cultured human skin fibroblasts," Biochemical and Biophysical Research Communications, vol. 208, no. 2, pp. 470-475, 1995.
33. A. W. Orr, J. M. Sanders, M. Bevard, E. Coleman, I. J. Sarembock, and M. A. Schwartz, "The subendothelial extracellular matrix modulates NF-kappaB activation by flow: a potential role in atherosclerosis," Journal of Cell Biology, vol. 169, no. 1, pp. 191-202, 2005.
34. A. W. Orr, R. Stockton, M. B. Simmers et al., "Matrix-specific p21-activated kinase activation regulates vascular permeability in atherogenesis," Journal of Cell Biology, vol. 176, no. 5, pp. 719-727, 2007.
35. A. Genasetti, D. Vigetti, M. Viola et al., "Hyaluronan and human endothelial cell behavior," Connective Tissue Research, vol. 49, no. 3-4, pp. 120-123, 2008.
36. D. Vigetti, A. Genasetti, E. Karousou et al., "Proinflammatory cytokines induce hyaluronan synthesis and monocyte adhesion in human endothelial cells through hyaluronan synthase 2 (HAS2) and the nuclear factor-κB (NF-κB) pathway," The Journal of Biological Chemistry, vol. 285, no. 32, pp. 24639-24645, 2010.
37. B. Ruffell and P. Johnson, "The regulation and function of hyaluronan binding by CD44 in the immune system," 2009.
38. D. Vigetti, M. Clerici, S. Deleonibus et al., "Hyaluronan synthesis is inhibited by adenosine monophosphate-activated protein kinase through the regulation of HAS2 activity in human aortic smooth muscle cells," Journal of Biological Chemistry, vol. 286, no. 10, pp. 7917-7924, 2011.
39. D. Vigetti, S. Deleonibus, P. Moretto et al., "Role of UDP-Nacetylglucosamine (GlcNAc) and O-GlcNacylation of hyaluronan synthase 2 in the control of chondroitin sulfate and hyaluronan synthesis," The Journal of Biological Chemistry, vol. 287, no. 42, pp. 35544-35555, 2012.
40. D. Vigetti, M. Ori, M. Viola et al., "Molecular cloning and characterization of UDP-glucose dehydrogenase from the amphibian Xenopus laevis and its involvement in hyaluronan synthesis," Journal of Biological Chemistry, vol. 281, no. 12, pp. 8254-8263, 2006.
41. D. Vigetti, M. Rizzi, M. Viola et al., "The effects of 4-methylumbelliferone on hyaluronan synthesis, MMP2 activity, proliferation, and motility of human aortic smooth muscle cells," Glycobiology, vol. 19, no. 5, pp. 537-546, 2009.
42. H. D. Grahame, "AMPK: a target for drugs and natural products with effects on both diabetes and cancer," Diabetes, vol. 62, no. 7, pp. 2164-2172, 2013.
43. I. Pernicova and M. Korbonits, "Metformin-mode of action and clinical implications for diabetes and cancer," Nature Reviews Endocrinology, vol. 10, no. 3, pp. 143-156, 2014.
44. C. Butkinaree, K. Park, and G. W. Hart, "O-linked β-N-acetylglucosamine (O-GlcNAc): extensive crosstalk with phosphorylation to regulate signaling and transcription in response to nutrients and stress," Biochimica et Biophysica Acta (BBA)-General Subjects, vol. 1800, no. 2, pp. 96-106, 2010.
45. G. W. Hart, M. P. Housley, and C. Slawson, "Cycling of O-linked β-N-acetylglucosamine on nucleocytoplasmic proteins," Nature, vol. 446, no. 7139, pp. 1017-1022, 2007.
46. M. G. Buse, "Hexosamines, insulin resistance, and the complications of diabetes: current status," American Journal of Physiology-Endocrinology and Metabolism, vol. 290, no. 1, pp. E1-E8, 2006.
47. B. Laczy, B. G. Hill, K. Wang et al., "Protein O-GlcNAcylation: a new signaling paradigm for the cardiovascular system," The American Journal of Physiology-Heart and Circulatory Physiology, vol. 296, no. 1, pp. H13-H28, 2009.
48. J. Nigro, N. Osman, A. M. Dart, and P. J. Little, "Insulin resistance and atherosclerosis," Endocrine Reviews, vol. 27, no. 3, pp. 242-259, 2006.
49. L. Heickendorff, T. Ledet, and L. M. Rasmussen, "Glycosaminoglycans in the human aorta in diabetes mellitus: a study of tunica media from areas with and without atherosclerotic plaque," Diabetologia, vol. 37, no. 3, pp. 286-292, 1994.
50. T. O. McDonald, R. G. Gerrity, C. Jen et al., "Diabetes and arterial extracellular matrix changes in a porcine model of atherosclerosis," Journal of Histochemistry and Cytochemistry, vol. 55, no. 11, pp. 1149-1157, 2007.
51. E. Karousou, M. Kamiryo, S. S. Skandalis et al., "The activity of hyaluronan synthase 2 is regulated by dimerization and ubiquitination," The Journal of Biological Chemistry, vol. 285, no. 31, pp. 23647-23654, 2010.
52. D. Vigetti, S. Deleonibus, P. Moretto et al., "Natural antisense transcript for hyaluronan synthase 2 (HAS2-AS1) induces transcription of HAS2 via proteinO-GlcNAcylation," The Journal of Biological Chemistry, vol. 289, no. 42, pp. 28816-28826, 2014.
53. H. Chao and A. P. Spicer, "Natural antisense mRNAs to hyaluronan synthase 2 inhibit hyaluronan biosynthesis and cell proliferation," The Journal of Biological Chemistry, vol. 280, no. 30, pp. 27513-27522, 2005.
54. D. R. Michael, A. O. Phillips, A. Krupa et al., "The human hyaluronan synthase 2 (HAS2) gene and its natural antisense RNA exhibit coordinated expression in the renal proximal tubular epithelial cell," The Journal of Biological Chemistry, vol. 286, no. 22, pp. 19523-19532, 2011.
55. M. A. Faghihi, F. Modarresi, A. M. Khalil et al., "Expression of a noncoding RNA is elevated in Alzheimers disease and drives rapid feed-forward regulation of beta-secretase," Nature Medicine, vol. 14, no. 7, pp. 723-730, 2008.
56. D. F. Allison, J. J. Wamsley, M. Kumar et al., "Modification of RelA by O-linked N-acetylglucosamine links glucose metabolism to NF-κB acetylation and transcription," Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 42, pp. 16888-16893, 2012.
57. D. Vigetti, M. Viola, E. Karousou et al., "Epigenetics in extracellular matrix remodeling and hyaluronan metabolism," FEBS Journal, vol. 281, no. 22, pp. 4980-4992, 2014.
58. T. R. Mercer and J. S. Mattick, "Structure and function of long noncoding RNAs in epigenetic regulation," Nature Structural and Molecular Biology, vol. 20, no. 3, pp. 300-307, 2013.
59. M. Magistri, M. A. Faghihi, G. St Laurent, and C. Wahlestedt, "Regulation of chromatin structure by long noncoding RNAs: focus on natural antisense transcripts," Trends in Genetics, vol. 28, no. 8, pp. 389-396, 2012.
60. J. T. Lee, "Epigenetic regulation by long noncoding RNAs," Science, vol. 338, no. 6113, pp. 1435-1439, 2012.
61. A. C. Doran, N. Meller, and C. A. McNamara, "Role of smooth muscle cells in the initiation and early progression of atherosclerosis," Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 28, no. 5, pp. 812-819, 2008.
62. A. Sica and A. Mantovani, "Macrophage plasticity and polarization: in vivo veritas," The Journal of Clinical Investigation, vol. 122, no. 3, pp. 787-795, 2012.
63. M. Y. Chang, Y. Tanino, V. Vidova et al., "Reprint of: a rapid increase in macrophage-derived versican and hyaluronan in infectious lung disease," Matrix Biology, vol. 35, pp. 162-173, 2014.
64. P. Libby, P. M. Ridker, and G. K. Hansson, "Progress and challenges in translating the biology of atherosclerosis," Nature, vol. 473, no. 7347, pp. 317-325, 2011.
65. R. Stocker and J. F. Keaney Jr., "Role of oxidative modifications in atherosclerosis," Physiological Reviews, vol. 84, no. 4, pp. 1381-1478, 2004.
66. T. Hevonoja, M. O. Pentikäinen, M. T. Hyvönen, P. T. Kovanen, and M. Ala-Korpela, "Structure of low density lipoprotein (LDL) particles: basis for understand ing molecular changes in modified LDL," Biochimica et Biophysica Acta, vol. 1488, no. 3, pp. 189-210, 2000.
67. H. Yoshida and R. Kisugi, "Mechanisms of LDL oxidation," Clinica Chimica Acta, vol. 411, no. 23-24, pp. 1875-1882, 2010.
68. S. Mitra, T. Goyal, and J. L. Mehta, "Oxidized LDL, LOX-1 and atherosclerosis," Cardiovascular Drugs and Therapy, vol. 25, no. 5, pp. 419-429, 2011.
69. M. Viola, B. Bartolini, D. Vigetti et al., "Oxidized low density lipoprotein (LDL) affects hyaluronan synthesis in human aortic smooth muscle cells," The Journal of Biological Chemistry, vol. 288, no. 41, pp. 29595-29603, 2013.
70. D. Hong, Y.-P. Bai, H.-C. Gao et al., "Ox-LDL induces endothelial cell apoptosis via the LOX-1-dependent endoplasmic reticulum stress pathway," Atherosclerosis, vol. 235, no. 2, pp. 310-317, 2014.
71. I. Tabas and D. Ron, "Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress," Nature Cell Biology, vol. 13, no. 3, pp. 184-190, 2011.
72. D. Vigetti, A. Genasetti, E. Karousou et al., "Modulation of hyaluronan synthase activity in cellular membrane fractions," The Journal of Biological Chemistry, vol. 284, no. 44, pp. 30684-30694, 2009.
73. D. Vigetti, E. Karousou, M. Viola, and A. Passi, "Analysis of hyaluronan synthase activity," in Glycosaminoglycans, vol. 1229 of Methods in Molecular Biology, pp. 201-208, Springer, New York, NY, USA, 2015.
74. A. C. Calkin and P. Tontonoz, "Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR," Nature Reviews Molecular Cell Biology, vol. 13, no. 4, pp. 213-224, 2012.